Gut bacteria influence brain development

Translate to Spanish or other 102 languages!

Starting points for the development of appropriate therapies are provided by the biomarkers that the interdisciplinary team was able to identify. Image for illustration purposes.

Mega Doctor News

- Advertisement -

By University of Vienna

Newswise — Complex interplay: the gut-immune-brain axis
The early development of the gut, the brain and the immune system are closely interrelated. Researchers refer to this as the gut-immune-brain axis. Bacteria in the gut cooperate with the immune system, which in turn monitors gut microbes and develops appropriate responses to them. In addition, the gut is in contact with the brain via the vagus nerve as well as via the immune system. “We investigated the role this axis plays in the brain development of extreme preterm infants,” says the first author of the study, David Seki. “The microorganisms of the gut microbiome – which is a vital collection of hundreds of species of bacteria, fungi, viruses and other microbes – are in equilibrium in healthy people. However, especially in premature babies, whose immune system and microbiome have not been able to develop fully, shifts are quite likely to occur. These shifts may result in negative effects on the brain,” explains the microbiologist and immunologist. 

Patterns in the microbiome provide clues to brain damage
“In fact, we have been able to identify certain patterns in the microbiome and immune response that are clearly linked to the progression and severity of brain injury,” adds David Berry, microbiologist and head of the research group at the Centre for Microbiology and Environmental Systems Science (CMESS) at the University of Vienna as well as Operational Director of the Joint Microbiome Facility of the Medical University of Vienna and University of Vienna. “Crucially, such patterns often show up prior to changes in the brain. This suggests a critical time window during which brain damage of extremely premature infants may be prevented from worsening or even avoided.” 

Comprehensive study of the development of extremely premature infants
Starting points for the development of appropriate therapies are provided by the biomarkers that the interdisciplinary team was able to identify. “Our data show that excessive growth of the bacterium Klebsiella and the associated elevated γδ-T-cell levels can apparently exacerbate brain damage,” explains Lukas Wisgrill, Neonatologist from the Division of Neonatology, Pediatric Intensive Care Medicine and Neuropediatrics at the Department of Pediatric and Adolescent Medicine at the Medical University of Vienna. “We were able to track down these patterns because, for a very specific group of newborns, for the first time we explored in detail how the gut microbiome, the immune system and the brain develop and how they interact in this process,” he adds. The study monitored a total of 60 premature infants, born before 28 weeks gestation and weighing less than 1 kilogram, for several weeks or even months. Using state-of-the-art methods – the team examined the microbiome using 16S rRNA gene sequencing, among other methods – the researchers analyzed blood and stool samples, brain wave recordings (e.g. aEEG) and MRI images of the infants’ brains. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Recognizes November as “National Hospice and Palliative Care” Month

DHR Health is pleased to recognize November as “National Hospice and Palliative Care Month.”  As we highlight National Hospice and Palliative Care Month, let us remember that healthcare is not solely about treating diseases but also about care for people at end of life.

STHS Heart Earns Healthgrades Five-Star Rating for Pacemaker Procedures

Healthgrades, the leading online resource for information about physicians and hospitals, has named STHS Heart a Five-Star Recipient for Pacemaker Procedures in 2027 for the second consecutive year, recognizing the facility's superior clinical outcomes and commitment to patient care.

Renaissance Cancer Foundation to Host 16th Anniversary “Viva la Vida” Gala, Nov. 21st

 The Renaissance Cancer Foundation, a non-profit organization of DHR Health, is excited to announce its 16th anniversary gala, featuring Miami’s premier party band, Extasy. The fundraising event is set to take place on November 21, 2026, at the Edinburg Conference Center at Renaissance, located at 118 Paseo Del Prado in Edinburg.

Op-ED: More than a ‘Smokers Disease’: Why Lung Cancer Awareness Must Become a Priority

In the wake of Pope Leo XIV’s recent lung cancer diagnosis, public interest in the disease has surged, underscoring the important role prevention and early detection play in achieving better outcomes.
- Advertisement -